DE60025215D1 - L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit - Google Patents

L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit

Info

Publication number
DE60025215D1
DE60025215D1 DE60025215T DE60025215T DE60025215D1 DE 60025215 D1 DE60025215 D1 DE 60025215D1 DE 60025215 T DE60025215 T DE 60025215T DE 60025215 T DE60025215 T DE 60025215T DE 60025215 D1 DE60025215 D1 DE 60025215D1
Authority
DE
Germany
Prior art keywords
propionylcarnitine
acetylcarnitine
prevention
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025215T
Other languages
English (en)
Other versions
DE60025215T2 (de
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE60025215D1 publication Critical patent/DE60025215D1/de
Publication of DE60025215T2 publication Critical patent/DE60025215T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60025215T 1999-07-28 2000-07-25 L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit Expired - Lifetime DE60025215T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999RM000483A IT1306179B1 (it) 1999-07-28 1999-07-28 Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM990483 1999-07-28
PCT/IT2000/000313 WO2001007039A2 (en) 1999-07-28 2000-07-25 L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases

Publications (2)

Publication Number Publication Date
DE60025215D1 true DE60025215D1 (de) 2006-02-02
DE60025215T2 DE60025215T2 (de) 2006-07-13

Family

ID=11406910

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025215T Expired - Lifetime DE60025215T2 (de) 1999-07-28 2000-07-25 L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit

Country Status (20)

Country Link
US (2) US6653349B1 (de)
EP (1) EP1200077B1 (de)
AR (1) AR024981A1 (de)
AT (1) ATE314064T1 (de)
AU (1) AU779094B2 (de)
CA (1) CA2378724C (de)
CZ (1) CZ20024A3 (de)
DE (1) DE60025215T2 (de)
DK (1) DK1200077T3 (de)
ES (1) ES2254206T3 (de)
HU (1) HU229185B1 (de)
IL (1) IL147410A0 (de)
IT (1) IT1306179B1 (de)
MX (1) MXPA02000911A (de)
NO (1) NO20020369L (de)
PL (1) PL208961B1 (de)
SK (1) SK952002A3 (de)
TN (1) TNSN00163A1 (de)
TR (1) TR200200224T2 (de)
WO (1) WO2001007039A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011977B2 (en) * 1999-01-30 2006-03-14 Sigma-Tau Pharmaceuticals, Inc. Quantification of carnitine levels in dialysis patients
US7238531B2 (en) * 1999-01-30 2007-07-03 Pediatrix Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
US7297545B2 (en) * 1999-01-30 2007-11-20 Pediatrix Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
US7709539B2 (en) * 2004-08-11 2010-05-04 Chang Gung University Therapeutic use of resveratrol for hyperglycemia
US20060153934A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and magnesium
WO2007022344A2 (en) * 2005-08-17 2007-02-22 Hill's Pet Nutrition, Inc. Methods and compositions for the preventioin and treatment of kidney disease
ES2385169B1 (es) * 2010-12-22 2013-09-23 Servicio Andaluz De Salud Uso de la l-carnitina y sus composiciones, para el tratamiento y la prevención del daño renal.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0514928B1 (de) * 1991-05-24 1997-08-20 Wakamoto Pharmaceutical Co., Ltd. Verfahren zur Diagnose von Nierenkrankheiten durch Nachweisung von Albuminfragmenten
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.
IT1291113B1 (it) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1295408B1 (it) * 1997-10-03 1999-05-12 Sigma Tau Ind Farmaceuti Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.

Also Published As

Publication number Publication date
EP1200077A2 (de) 2002-05-02
PL354412A1 (en) 2004-01-12
ES2254206T3 (es) 2006-06-16
CA2378724A1 (en) 2001-02-01
HUP0202314A2 (en) 2002-10-28
EP1200077B1 (de) 2005-12-28
ITRM990483A0 (it) 1999-07-28
WO2001007039A2 (en) 2001-02-01
ITRM990483A1 (it) 2001-01-28
MXPA02000911A (es) 2002-10-23
AU6469200A (en) 2001-02-13
CZ20024A3 (cs) 2002-06-12
US7585896B2 (en) 2009-09-08
DE60025215T2 (de) 2006-07-13
DK1200077T3 (da) 2006-04-24
TNSN00163A1 (fr) 2005-11-10
TR200200224T2 (tr) 2002-08-21
IT1306179B1 (it) 2001-05-30
US6653349B1 (en) 2003-11-25
HU229185B1 (en) 2013-09-30
NO20020369L (no) 2002-03-21
WO2001007039A3 (en) 2001-03-29
PL208961B1 (pl) 2011-06-30
SK952002A3 (en) 2002-06-04
IL147410A0 (en) 2002-08-14
ATE314064T1 (de) 2006-01-15
AU779094B2 (en) 2005-01-06
US20040057994A1 (en) 2004-03-25
NO20020369D0 (no) 2002-01-23
HUP0202314A3 (en) 2003-03-28
AR024981A1 (es) 2002-11-06
CA2378724C (en) 2008-10-14

Similar Documents

Publication Publication Date Title
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60026627D1 (de) Reboxetin zur Behandlung von Fibromyalgie und anderen somatoformen Störungen
DE69922914D1 (de) Stimulationssystem zur Behandlung von Erkrankungen bezüglich des Magenspeiseröhrenreflux
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60035378D1 (de) Gerät zur Behandlung von Bandscheiben
DE69903543T2 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE60112340D1 (de) Absorbierende Matte zur Behandlung von Ausscheidungen
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE369130T1 (de) Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE60025215D1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ATE299371T1 (de) Antikonvulsiva zur behandlung von autismus
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen
DE60036723D1 (de) Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition